We present a case of a term infant who developed refractory supraventricular tachycardia (SVT) that responded to a high dose of electrical shock. The exact cause for SVT remained obscure.

Health-related quality of life (HRQoL) is a multi-dimensional concept that includes domains related to physical, mental, emotional, and social functioning. Kansas City Cardiomyopathy Questionnaire (KCCQ) is typically utilized to assess the HRQoL after TAVR.

Background: Cystatin C, a marker for early stage chronic kidney dysfunction, mediates the pathogenesis of cardiovascular diseases. Objectives: To assess the relation between level of serum Cystatin C and severity of coronary artery disease (CAD) in patients without chronic kidney disease (CKD). Patients and Methods: In this cross-sectional study, we included 80 patients with CAD divided in two groups (group I with acute coronary artery disease and group II with chronic stable coronary artery disease) 40 patients each and acquired their demographic characteristics, medical histories, and listings of the concurrent medications they were taking. All patients with CAD underwent ECG, echocardiography, coronary angiography, serum Cystatin C level, cardiac enzymes and other routine laboratory tests. Results: As regard demographic data and comorbidities there was no significant difference between the two groups as regard gender, diabetes mellitus, hypertension or smoking. Also, As regard level of serum Cystatin C, the mean and SD in 1 vessel affection was 0.92±0.07 while in 2 vessels affection was 1.07±0.13 and 3 vessels affection was 1.41±0.05 with (P< 0.01). Finally, there was a highly significant difference as regard Cystatin C level with mean and SD 1.21±0.18 in ST-segment elevation MI while mean and SD was 0.96±0.09 in Non ST-segment MI or unstable angina with (P< 0.01). There was a statistically significant correlation between level of Cystatin C and severity of CAD (p < 0.05). Conclusion: Serum cystatin C has a significant effect on the severity of coronary artery disease (CAD), being higher in patients with 3 vessels disease and severe CAD.

Introduction: Chronic pulmonary heart is the main cardiovascular complication of chronic obstructive pulmonary disease. The aims of our study were to evaluate the right ventricular systolic function in patients with chronic obstructive pulmonary disease and to investigate the relationship between parameters of right ventricular function and pulmonary function testing data. Methodology: A multicenter cross-sectional study was conducted between January 2013 and July 2013 in cardiology and pulmonology department in Dakar. Was included all in or outpatient diagnosed for chronic obstructive pulmonary disease. Results: 30 patients were evaluated in this cohort. The mean age was 62.4 years. Male predominance was noted (sex ratio of 9). Right heart failure was found in 7 patients (23.3%) had. Right ventricule enlargement was noted in 12 patients (40%). Mean sPAP was 58.58 ± 23.59 mmHg. Pulmonary arterial hypertension was found in 16 (53.3%) patients. TAPSE was impaired in 7 patients (23.3%). Reduction of right ventricule fractional area change was present in 14 (46.6%) patients. S’ of the tricuspid annulus velocity was reduced in 11 (33%) patients. Parameters correlated with the severity of chronic obstructive pulmonary disease were: TAPSE (p= 0.0099), right ventricule fractional area change (p = 0.0095), S’ of the annular tricuspid (p= 0.0173) TEI index (p= 0.038) and Pulmonary arterial hypertension (p= 0,023). Conclusion: Evaluation of right ventricular systolic function in chronic obstructive pulmonary disease is fundamental and must use multiple parameters.

Heart Failure (HF) has become a major cause of death and hospitalization among people older than 60 year. Lack of available data and registries from different countries that may aid in understanding the burden of the disease does exist. The aim of the lebanese Geitawi Hospital-University Medical Center (LGH-UMC) heart failure registry is to point toward the incidence of heart failure, in patients with suspected dyspnea, during a 7 months period in a single university medical center based on Trans-thoracic echocardiography (TTE) findings with emphasis on its etiology. Study population The LGH-HFR includes inpatients and outpatients (=18 years) presenting for further evaluation of possible HF by performing a TTE after suspicious clinical findings. Patients with clinical impression of possible heart failure were reported to LGH-HFR by their doctors. The final decision to register a patient in the LGH-HFR is made by a single cardiologist to ensure the validity of the clinical suspicion. Approximately 1422 patients with clinically suspicion HF were registered in the LGH-HFR between 1.1.2018 and 31.7.2018. Main variables and descriptive data Our study will be a retrospective cohort analysis of data collected from the LGH-HFR between 1.1.2018 and 31.7.2018. Our number of studied patients is about 1422. The main variables recorded in the LGH-HFR are related to the TTE findings: LVEDV, LVEF, presence of LVH, the presence of diastolic dysfunction, documentation of any valvulopathies, measurements of PAPs. Furthermore, pro-BNP level and basic patient characteristics (age and sex) will be recorded. The findings then will be pooled according to the documentation of heart failure, either systolic or diastolic. Furthermore, specific TTE findings will be mentioned in each case after correlation with the HF type pointing toward the possible etiology of the cardiac function degradation. Results of our study will be reported back to clinicians to promote awareness for HF and communicated with the HFRs of different hospitals and LSC in order to optimize the standards of care regarding HF and discussing the cost effectiveness issue if possible. Conclusion The LGH-HFR is a valuable tool for continuous improvement of quality of care in patients and awareness regarding HF in Lebanon. Furthermore, it will be an important resource for the Lebanese registry-based HF research once available.